fda compounding semaglutide warning 2025 october Beyond the Headlines: Letters to GLP-1 Compounders Diabetes advocacy group discourages use

Additional well-conducted and well-reported studies are needed, accompanied by the use of accepted definitions and causality assessment tools to address the lack of published literature regarding this issue

We herein refer to these compounds as 6-prenylapigenin (6-PA) and 6-geranylapigenin (6-GA), respectively

Quantitative data were expressed as the mean standard deviation (SD)

The updated 2018 diagnostic criteria for PCOS require the presence of at least two of the following three features: (1) oligo/anovulation, (2) clinical and/or biochemical hyperandrogenism, and (3) PCO identified by the presence of 20 antral follicles per ovary on transvaginal ultrasound, with or without increased ovarian volume